COVID-19 management landscape: A need for an affordable platform to manufacture safe and efficacious biotherapeutics and prophylactics for the developing countries

To gain world-wide control over COVID-19 pandemic, it is necessary to have affordable and accessible vaccine and monoclonal antibody technologies across the globe. In comparison to the western countries, Asian and African countries have less percentage of vaccination done which warrants urgent atten...

Descripción completa

Detalles Bibliográficos
Autores principales: Pidiyar, Vyankatesh, Kumraj, Ganesh, Ahmed, Kafil, Ahmed, Syed, Shah, Sanket, Majumder, Piyali, Verma, Bhawna, Pathak, Sarang, Mukherjee, Sushmita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148927/
https://www.ncbi.nlm.nih.gov/pubmed/35914959
http://dx.doi.org/10.1016/j.vaccine.2022.05.065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148927/
https://www.ncbi.nlm.nih.gov/pubmed/35914959
http://dx.doi.org/10.1016/j.vaccine.2022.05.065

Ejemplares similares